GS
Gursanjam Singh Sodhi
About Gursanjam Singh Sodhi
Data last updated:
Gursanjam Singh Sodhi is a Director at Sanman Biotech Private Limited (since 2025) and Director at Blexion Pharmaceuticals Private Limited (since 2025). The companies operate in Pharma. The largest current company by reported revenue is Sanman Biotech Private Limited at ₹1.38 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sanman Biotech Private Limited U46497PB2024PTC062711 | Director | 17 Feb 2025 | 2024 | ₹1.38 Cr (FY 2025) | Active |
| Blexion Pharmaceuticals Private Limited U47721PB2024PTC062848 | Director | 28 Apr 2025 | 2024 | Active |
Board colleagues of Gursanjam Singh Sodhi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Upinder Kaur Sodhi | 10811607 | Sanman Biotech Private Limited , Blexion Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Gursanjam Singh Sodhi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gursanjam Singh Sodhi
Gursanjam Singh Sodhi currently holds 2 directorships: Sanman Biotech Private Limited (Director, since 17 Feb 2025, revenue ₹1.38 Cr (FY 2025)); Blexion Pharmaceuticals Private Limited (Director, since 28 Apr 2025).
Gursanjam Singh Sodhi was first appointed on 17 Feb 2025 as Director at Sanman Biotech Private Limited.
The current boards of Gursanjam Singh Sodhi's companies include Upinder Kaur Sodhi (Sanman Biotech Private Limited).